Medpace Holdings, Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, Medpace Holdings, Inc. reported net income of $451.12M on revenue of $2.53B. Operating cash flow was $713.22M and capital expenditures were $31.36M, leaving $681.87M of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $421.58M | $436.15M | $704.59M | $860.97M | $925.92M | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| Operating income | $52.49M | $64.86M | $101.05M | $127.26M | $167.04M | $198.62M | $278.70M | $336.82M | $446.87M | $534.93M |
| Net income | $13.43M | $39.12M | $73.19M | $100.44M | $145.38M | $181.85M | $245.37M | $282.81M | $404.39M | $451.12M |
| Diluted EPS | $0.37 | $0.98 | $1.97 | $2.67 | $3.84 | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |
| Operating cash flow | $91.73M | $97.39M | $156.58M | $201.87M | $258.68M | $263.33M | $388.05M | $433.37M | $608.82M | $713.22M |
| Capital expenditures | $13.54M | $11.72M | $16.02M | $17.91M | $31.34M | $28.27M | $36.88M | $36.65M | $36.55M | $31.36M |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | — | 21.1% | 17.8% |
| Dec 2024 | — | 21.2% | 19.2% |
| Dec 2023 | — | 17.9% | 15.0% |
| Dec 2022 | — | 19.1% | 16.8% |
| Dec 2021 | — | 17.4% | 15.9% |
Source: SEC EDGAR XBRL company facts for CIK 1668397 (raw data). Most recent filing in this dataset: 10-Q filed Oct 22, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.